Combination of gemcitabine and cisplatin for biliary tract cancer: A platform to build on

被引：22
|
作者：
Razumilava, Nataliya [1 ]
Gores, Gregory J. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷 / 03期
关键词：
PHASE-II;
D O I：
10.1016/j.jhep.2010.10.010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：577 / 578
页数：2
相关论文
共 50 条
  • [41] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    不详
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (5) : 280 - 280
  • [42] Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer (TOPAZ-1)
    Choe, Jung Wan
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 82 (02): : 105 - 106
  • [43] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 280 - 280
  • [44] Efficacy and safety of S-1 following gemcitabine with cisplatin for biliary tract cancer
    Inoue, H.
    Yamazaki, K.
    Shirasu, H.
    Kawakami, T.
    Todaka, A.
    Tsushima, T.
    Hamauchi, S.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S111 - S112
  • [45] Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer
    Uwagawa, Tadashi
    Sakamoto, Taro
    Abe, Kyohei
    Okui, Norimitsu
    Hata, Daigo
    Shiba, Hiroaki
    Futagawa, Yasuro
    Aiba, Keisuke
    Yanaga, Katsuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 191 - 196
  • [46] Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer
    Moriwaki, Toshikazu
    Ishida, Hiroyasu
    Araki, Masahiro
    Endo, Shinji
    Yoshida, Shigemasa
    Kobayashi, Mariko
    Hamano, Yukako
    Sugaya, Akinori
    Shimoyamada, Masahiro
    Hasegawa, Naoyuki
    Imanishi, Mamiko
    Ito, Yuka
    Sato, Daiki
    Hyodo, Ichinosuke
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (09) : 669 - 674
  • [47] Pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract cancer: phase 3 KEYNOTE-966 trial in progress
    Vogel, A.
    Finn, R.
    Kelley, R.
    Furuse, J.
    Edeline, J.
    Ren, Z.
    Su, S.
    Malhotra, U.
    Siegel, A.
    Valle, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S122 - S122
  • [48] Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer
    Aznab, Mozaffar
    Khazaei, Mansour
    IRANIAN JOURNAL OF CANCER PREVENTION, 2016, 9 (03) : 1 - 3
  • [49] Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer
    Tadashi Uwagawa
    Taro Sakamoto
    Kyohei Abe
    Norimitsu Okui
    Daigo Hata
    Hiroaki Shiba
    Yasuro Futagawa
    Keisuke Aiba
    Katsuhiko Yanaga
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 191 - 196
  • [50] EVALUATION OF CHEMOTHERAPY WITH CISPLATIN-GEMCITABINE AFTER FAILURE OF GEMCITABINE MONOTHERAPY FOR UNRESECTABLE OR RECURRENT BILIARY TRACT CANCER
    Kameda, R.
    Ando, T.
    Kobayashi, S.
    Ueno, M.
    Ohkawa, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 162 - 162
12345